SGF29

Across TCGA pan-cancer cohorts, SGF29 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated SGF29 data layer compared with 24 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher SGF29 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated SGF29 expression acts as an unfavorable survival marker, although some lineages such as LUAD and PDAC show a favorable association.

LUAD, HNSC, and PDAC are the cancer types where SGF29 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	III,IV	0.873	0.295	<.001	45	view →
HNSC	OS	Quartile	III,IV	0.719	0.993	.001	28	view →
PDAC	OS	Median	IV	0.951	0.381	.006	12	view →
LSCC	OS	Quartile	II,III,IV	0.927	0.527	.017	4	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

SGF29–LUAD (DFS)

Open the LUAD breakdown →